Subthreshold doses of nebulized prostacyclin and rolipram synergistaically protect against lung ischemia-reperfusion. [electronic resource]
Producer: 20030428Description: 814-21 p. digitalISSN:- 0041-1337
- Animals
- Capillary Permeability -- drug effects
- Cyclic AMP -- metabolism
- Disease Models, Animal
- Drug Synergism
- Epoprostenol -- pharmacology
- Female
- Lung Transplantation
- Male
- Microcirculation -- drug effects
- Nebulizers and Vaporizers
- Phosphodiesterase Inhibitors -- pharmacology
- Platelet Aggregation Inhibitors -- pharmacology
- Pulmonary Circulation -- drug effects
- Pulmonary Wedge Pressure -- drug effects
- Rabbits
- Reperfusion Injury -- drug therapy
- Rolipram -- pharmacology
- Weight Gain -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.